MultiCASE expert systems and the REACH initiative

Toxicology Mechanisms and Methods

Volumn 18, Issue 2-3, 2008, Pages 159-175

  Saiakhov, Roustem D ^a   Klopman, Gilles ^a,b  

^a MULTICASE Inc   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Carcinogenicity; CASE; Environmental; Expert System; FDA; In Silico; MC4PC; MCASE; Mutagenicity; Prediction; QSAR; REACH; Toxicity

Indexed keywords

ACUTE TOXICITY; ALGORITHM; AREA UNDER THE CURVE; CARCINOGENICITY; CHRONIC TOXICITY; COMPUTER PROGRAM; DEVELOPMENTAL BIOLOGY; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; EXPERT SYSTEM; GENOTOXICITY; HUMAN; MOLECULAR DYNAMICS; MUTAGENICITY; NONHUMAN; PRACTICE GUIDELINE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; TOXICOLOGY;

EID: 40949161033     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701857460     Document Type: Review

References (70)

1. Accelrys. TOPKAT. http://www.accelrys.com/products/topkat/. Accessed October 1, 2007.
2. Albertini, S., and Zimmermann, F. K. The detection of chemically induced chromosomal malsegregation in Saccharomyces cerevisiae D61.M: a literature survey (1984-1990). Mutat. Res. 258:237-258.
3. Ashby, J., and Tennant, R. W. 1991. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257(3):229-306.
4. Cronin, M. T. D., Jaworska, J. S., Walker, J. D., Comber, M. H. I., Watts, C. D., and Worth, A. P. 2003b. Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ. Health Perspect. 111(10):1391-1401.
5. Cronin, M. T. D., Walker, J. D., Jaworska, J. S., Comber, M. H. I., Watts, C. D., and Worth, A. P. 2003a. Use of QSARs in international decision-making frameworks to predict ecologic effects and environmental fate of chemical substances. Environ. Health Perspect. 111(10):1376-1390.
6. Cunningham, A. R., and Rosenkranz, H. S. 2001. Estimating the extent of the health hazard posed by high-production volume chemicals. Environ. Health Perspect.109:953-956.
7. Danish Ministry of the Environment, Environmental Protection Agency. 2006. Danish (Q)SAR Database. http://ecb.jrc.it/QSAR./ Accessed October 1, 2007.
8. European Chemicals Bureau. 2007a. REACH home page. http://ecb.jrc.it/ reach./ Accessed October 1, 2007.
9. European Chemicals Bureau. 2007b. ECB - Testing Methods: Annex V. http://ecb.jrc.it/testing-methods/annex5./ Accessed October 1, 2007.
10. European Chemicals Bureau. 2007c. Testing methods. http://ecb.jrc.it/ testing-methods./Accessed October 1, 2007.
11. Food and Drug Administration. 2007. Informatics and Computational Safety Analysis Staff (ICSAS) Programs and Activities. http://www.fda.gov/CDER/Offices/ OPS_IO/ICSAS.htm. Accessed October 1, 2007.
12. Frierson, M., Klopman, G., and Rosenkranz, H. S. 1986. Structure-activity relationships (SARs) among mutagens and carcinogens: a review. Env. Mutagens 8(2):283-327.
13. Ghanooni, M., Mattison, D. R., Zhang, Y. P., Macina, O. T., Rosenkranz, H. S., and Klopman, G. 1997. Structural determinants associated with risk of human developmental toxicity. Am. J. Obstet. Gynecol. 176:799-805.
14. Gomez, J., Macina, O. T., Mattison, D. R., Zhang, Y. P., Klopman, G., and Rosenkranz, H. S. 1999. Structural determinants of developmental toxicity in hamsters. Teratology 60:190-205.
15. Hardman, J., and Lipman, L. 1996. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill (Tx).
16. Jelovsek, F. R., Mattison, D. R., and Chen, J. J. 1989. Prediction of risk for human development toxicity: how important are animal studies for hazard identification? Obstet. Gynecol. 74:624-636.
17. Klopman, G. 1984. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Am Chem. Soc. 106:7315-7321.
18. Klopman, G. 1998. The MultiCASE Program II. Baseline Activity Identification Algorithm (BAIA). J. Chem. Inf. Comput. Sci. 38:78-81.
19. Klopman, G., and Bendale, R. D. 1989. Computer automated structure evaluation (CASE): a study of inhibitors of the thermolysin enzyme. J. Theor. Biol. 136(1):67-77.
20. Klopman, G., Frierson, M. R., and Rosenkranz, H. S. 1990. The structural basis of the mutagenicity of chemicals in Salmonella typhimurium: the Gene-Tox data base. Mutat. Res. 228:1-50.
21. Klopman, G., Ivanov, J., Saiakhov, R., and Chakravarti, S. 2005. MC4PC - an artificial intelligence approach to the discovery of structure toxic activity relationships (STAR). In: Helma, C. (Ed.), Predictive Toxicology Book, CRC Press, Boca Raton, pp. 423-457.
22. Klopman, G., and Kalos, A. N. 1986. Quantitative structure-activity relationships of beta-adrenergic agents. Application of the computer automated structure evaluation (CASE) technique of molecular fragment recognition. J. Theor. Biol. 118:199-214.
23. Klopman, G., and Macina, O. T. 1985. Use of the Computer Automated Structure Evaluation program in determining quantitative structure-activity relationships within hallucinogenic phenylalkylamines. J. Teor. Biol. 113(4):637-648.
24. Klopman, G., and Macina, O. T. 1987. Computer-automated structure evaluation of antileukemic 9-anilinoacridines. Mol. Pharmacol. 31:457-476.
25. Klopman, G., Macina, O. T., Levinson, M. E., and Rosenkranz, H. S. 1987. Computer automated structure evaluation of quinolone antibacterial agents. Antimicrob. Agents. Chemother. 31:1831-1840.
26. Klopman, G., Macina, O. T., Simon, E. J., and Hiller, J. M. 1986. Computer Automated Structure Evaluation of opiate alkaloids. Theochem 134:299-308.
27. Klopman, G., Namboodiri, K., and Kalos, A. 1985. In: Rein, R. (Ed.), The Molecular Basis of Cancer, New York: A. R. Liss, Inc., pp. 287-298.
28. Klopman, G., Ptchelintsev, D., Friersen, M., Pennisi, S., Renskers, K., and Dickens, M. 1993. Multiple Computer Automated Structure Evaluation methodology as an alternative to in-vivo eye irritation testing. Altern. Lab. Anim. ATLA 21(1):14-27.
29. Klopman, G., Saiakhov, R., and Rosenkranz, H. S. 2000. Multiple computer-automated structure evaluation study of aquatic toxicity II. Fathead minnow. Environ. Toxicol. Chem. 19:441-447.
30. Klopman, G., Saiakhov, R., Rosenkranz, H. S., and Hermens, J. L. M. 1999. Multiple Computer-Automated Structure Evaluation program study of aquatic toxicity 1: guppy. Environ. Toxicol. Chem. 18(11):2497-2505.
31. Klopman, G., and Sedykh, A. 2005. META. An expert system for the prediction of metabolic transformations. In: Helma, C. (Ed.), Predictive Toxicology Book, CRC Press, Boca Raton, pp. 458-465.
32. Klopman, G., Stefan, L., and Saiakhov, R. 2002. ADME evaluation 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. 17:253-263.
33. Klopman, G., and Stuart, S. E. 2003. Multiple computer-automated structure evaluation study of aquatic toxicity. III. Vibrio fischeri. Environ. Toxicol. Chem. 22(3):466-472.
34. Klopman, G., and Tu, M. 1999. Diversity analysis of 14 156 molecules tested by the National Cancer Institute for anti-HIV activity using the quantitative structure-activity relational expert system MCASE. J. Med. Chem. 42(6):992-998.
35. Klopman, G., and Venegas, R. E. 1986. CASE study of in vitro inhibition of sparteine monooxygenase. Acta Pharma. Jugosl. 36:189-208.
36. Klopman, G., and Zhu, H. 2001. Estimation of the aqueous solubility of organic molecules by the group contribution approach. J. Chem. Inf. Comput. Sci. 41:439-445.
37. Klopman, G., Zhu, H., Fuller, M. A., and Saiakhov, R. D. 2004. Searching for an enhanced predictive tool for mutagenicity. SAR QSAR Environ. Res. 15(4):251-263.
38. Labbauf, A., Klopman, G., and Rosenkranz, H. S. 1997. Dichotomous relationship between DNA reactivity and the induction of sister chromatid exchanges in vivo and in vitro. Mutat. Res. Fund. Mol. Mech. Mut. 377(1):37-52.
39. Lee, Y., Buchanan, B. G., and Aronis, J. M. 1998. Knowledge-based learning in exploratory science: Learning rules to predict rodent carcinogenicity. Mach. Learn. 30(2-3):217-240.
40. Lhasa Ltd. 2007. Predicting toxicity and metabolic fate. DEREK: general information. http://www.lhasalimited.org/index.php?cat=2&sub_cat=64. Last modified October 31, 2007.
41. Macina, O. T., Klopman, G., and Rosenkranz, H. S. 1997. Structural basis of sensory irritation. Inhal. Toxicol. 9(5):465-476.
42. Matthews, E. J., and Contrera, J. F. 1998. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. Regul. Toxicol. Pharm. 28(3):242-264.
43. Matthews, E. J., Kruhlak, N. L., Benz, R. D., Ivanov, J., Klopman, G., and Contrera, J. F. 2007. A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals. Reg. Toxicol. Pharm. 47:136-155.
44. Matthews, E. J., Kruhlak, N. L., Cimino, M. C., Benz, R. D., and Contrera, J. F. 2006a. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Reg. Toxicol. Pharm. 44:83-96.
45. Matthews, E. J., Kruhlak, N. L., Cimino, M. C., Benz, R. D., and Contrera, J. F. 2006b. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. Reg. Toxicol. Pharm. 44:97-110.
46. Mavournin, K. H., Blakey, D. H., Cimino, M. C., Salomone, M. F., and Heddle, J. A. 1990. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res 239:29-80.
47. MultiCASE Inc. 2007. Bioactivity Software. www.multicase.com. Last modified July 25, 2007.
48. Niemelå, J., and Wedebye, E. A. 2004. "Global" Multi-CASE Model For In Vitro Chromosomal Aberrations In Mammalian Cells. http://ecb.jrc.it/DOCUMENTS/QSAR/QSAR_DATASETS/CHROMOSOMAL_ABERRATIONS/ Mutagenicity_summary.doc. Accessed October 1, 2007.
49. Netzeva, T. I., Worth, A. P., Aldenberg, T., Benigni, R., Cronin, M. T., Gramatica, P., Jaworska, J. S., Kahn, S., Klopman, G., Marchant, C. A., Myatt, G., Nikolova-Jeliazkova, N., Patlewicz, G. Y., Perkins, R., Roberts, D. W., Schultz, T. W., Stanton, D. T., Sandt, J. J. M., van de, Tong, W. D., Veith, G., and Yang, C. H. 2005. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. ATLA 33:1-19.
50. Organisation for Economic Cooperation and Development (OECD). 2007. Chemicals Testing: OECD Guidelines for the Testing of Chemicals - Sections 1-5. http://www.oecd.org/document/22/0,2340,en_2649_34377_1916054_1_1_1_1,00.html. Accessed October 1, 2007.
51. Pearl, G. M., Livingston-Carr, S., and Durham, S. 2001. Integration of computational analysis as a sentinel tool in toxicological assessments. Curr. Top. Med. Chem. 1:247-255.
52. Rosenkranz, H. S., and Karol, M. H. 1999. Chemical carcinogenicity: can it be predicted from knowledge of mutagenicity and allergic contact dermatitis?. Mutat. Res. Fund. Mol. M. 431(1):81-91.
53. Rosenkranz, H. S., and Klopman, G. 1990a. Biophores to genotoxicity: the interaction of human and artificial intelligence. Mutagenesis 5:333-362.
54. Rosenkranz, H. S., and Klopman, G. 1990b. Structural basis of the mutagenicity of phenylazoaniline dyes. Mutat. Res. 221:217-234.
55. Rosenkranz, H. S., and Klopman, G. 1990c. Structural basis of the mutagenicity of chemicals in Salmonella typhimurium: the National Toxicology Program. Mutat. Res. 228:51-80.
56. Rosenkranz, H. S., and Klopman, G. 1993. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents. Environ. Mol. Mutagen.21:193-206.
57. Rosenkranz, H. S., Klopman, G., Zhang, Y. P., Graham, C., and Karol, M. H. 1999a. Relationship between allergic contact dermatitis and electrophilicity. Environ. Health Perspect.107:129-132.
58. Rosenkranz, H. S., Mersch-Sundermann, V., and Klopman, G. 1999b. SOS chromotest and mutagenicity in Salmonella: evidence for mechanistic differences. Mutat. Res. Fund. Mol. M. 431(1):31-38.
59. Rosenkranz, H. S., Mersch-Sundermann, V., and Klopman, G. 1999c. Structural determinants of developmental toxicity in hamsters. Teratology 60(4):190-205.
60. Rosenkranz, H. S., Zhang, Y. P., and Klopman, G. 1998. Studies on the potential for genotoxic carcinogenicity of fragrances and other chemicals. Food Chem. Toxicol. 36(8):687-696.
61. Schaper, M. 1993. Development of a database for sensory irritants and its use in establishing occupational exposure limits. Am. Ind. Hyg. Assoc. J. 54:488-544.
62. Schardein, J. L. 1993. Chemically Induced Birth Defects, Marcel Dekker, New York, p. 1128.
63. Sedykh, A. Y., and Klopman, G. 2006. A structural analogue approach to the prediction of the octanol-water partition coefficient. J. Chem. Inf. Modeling 46(4):1598-1603.
64. Stefan, L. 2002. In Silico Prediction of Absorption, Distribution, Metabolism and Elimination (ADME). PhD thesis, Cleveland, CASE.
65. Takihi, N., Rosenkranz, H. S., Klopman, G., and Mattison, D. R. 1994. Structural determinants of developmental toxicity. Risk Anal. 14:649-657.
66. Tichý, M. 2005. Experimental toxicology in-silico. Biomed. Pap. Med. Fac. 149(2):217-219.
67. Tucker, J. D., Auletta, A., Cimino, M. C., Dearfield, K. L., Jacobson-Kram, D., Tice, R. R., and Carrano, A. V. 1993. Sister-chromatid exchange: second report of the Gene-Tox Program. Mutat. Res. 297:101-180.
68. U.S. Environmental Protection Agency. 2007. ECOTOX Databases Mid-Continent Ecology Division. http://www.epa.gov/med/Prods Pubs/ecotox.htm. Accessed October 1, 2007.
69. Williams, G. M., Laspia, M. F., and Dunkel, V. C. 1982. Reliability of the hepatocyte primary culture/DNA repair test in testing of coded carcinogens and noncarcinogens. Mutat. Res. 97(5):359-370.
70. Zhu, X. Y., Zhang, Y. P., Klopman, G., and Rosenkranz, N. S. 1999. Thalidomide and metabolites: indications of the absence of 'genotoxic' carcinogenic potentials. Mutat. Res. Fund. Mol. M. 425(1):153-167.